Shepherd FA - Search Results

1

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC.

Rolfo C, Mack PC, Scagliotti GV, Baas P, Barlesi F, Bivona TG, Herbst RS, Mok TS, Peled N, Pirker R, Raez LE, Reck M, Riess JW, Sequist LV, Shepherd FA, Sholl LM, Tan DSW, Wakelee HA, Wistuba II, Wynes MW, Carbone DP, Hirsch FR, Gandara DR. Rolfo C, et al. Among authors: shepherd fa. J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6. J Thorac Oncol. 2018. PMID: 29885479 Free article. Review.

2

Economic analysis of the TAX 317 trial: docetaxel versus best supportive care as second-line therapy of advanced non-small-cell lung cancer.

Leighl NB, Shepherd FA, Kwong R, Burkes RL, Feld R, Goodwin PJ. Leighl NB, et al. Among authors: shepherd fa. J Clin Oncol. 2002 Mar 1;20(5):1344-52. doi: 10.1200/JCO.2002.20.5.1344. J Clin Oncol. 2002. PMID: 11870178

3

Molecular profiling of non-small cell lung cancer and correlation with disease-free survival.

Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, Liu N, Lu C, Woodgett J, Seiden I, Johnston M, Keshavjee S, Darling G, Winton T, Breitkreutz BJ, Jorgenson P, Tyers M, Shepherd FA, Tsao MS. Wigle DA, et al. Among authors: shepherd fa. Cancer Res. 2002 Jun 1;62(11):3005-8. Cancer Res. 2002. PMID: 12036904

4

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North America.

Jänne PA, Freidlin B, Saxman S, Johnson DH, Livingston RB, Shepherd FA, Johnson BE. Jänne PA, et al. Among authors: shepherd fa. Cancer. 2002 Oct 1;95(7):1528-38. doi: 10.1002/cncr.10841. Cancer. 2002. PMID: 12237922 Free article.

5

Second line chemotherapy for NSCLC: establishing a gold standard.

Fossella FV, Lynch T, Shepherd FA. Fossella FV, et al. Among authors: shepherd fa. Lung Cancer. 2002 Dec;38 Suppl 4:5-12. doi: 10.1016/s0169-5002(02)00167-8. Lung Cancer. 2002. PMID: 12480189 Review.

6

Pemetrexed in the treatment of non-small cell lung cancer.

Shepherd FA. Shepherd FA. Semin Oncol. 2002 Dec;29(6 Suppl 18):43-8. doi: 10.1053/sonc.2002.37470. Semin Oncol. 2002. PMID: 12571810 Review.

7

Expression and prognostic significance of kit, protein kinase B, and mitogen-activated protein kinase in patients with small cell lung cancer.

Blackhall FH, Pintilie M, Michael M, Leighl N, Feld R, Tsao MS, Shepherd FA. Blackhall FH, et al. Among authors: shepherd fa. Clin Cancer Res. 2003 Jun;9(6):2241-7. Clin Cancer Res. 2003. PMID: 12796392

8

Inhibitors of epidermal-growth-factor receptors: a review of clinical research with a focus on non-small-cell lung cancer.

Sridhar SS, Seymour L, Shepherd FA. Sridhar SS, et al. Among authors: shepherd fa. Lancet Oncol. 2003 Jul;4(7):397-406. doi: 10.1016/s1470-2045(03)01137-9. Lancet Oncol. 2003. PMID: 12850190 Review.

9

Ongoing and future trials of biologic therapies in lung cancer.

Bunn PA Jr, Shepherd FA, Sandler A, Le Chevalier T, Belani CP, Kosmidis PA, Scagliotti GV, Giaccone G. Bunn PA Jr, et al. Among authors: shepherd fa. Lung Cancer. 2003 Aug;41 Suppl 1:S175-86. doi: 10.1016/s0169-5002(03)00161-2. Lung Cancer. 2003. PMID: 12867076 Review.

10

Skp2 gene copy number aberrations are common in non-small cell lung carcinoma, and its overexpression in tumors with ras mutation is a poor prognostic marker.

Zhu CQ, Blackhall FH, Pintilie M, Iyengar P, Liu N, Ho J, Chomiak T, Lau D, Winton T, Shepherd FA, Tsao MS. Zhu CQ, et al. Among authors: shepherd fa. Clin Cancer Res. 2004 Mar 15;10(6):1984-91. doi: 10.1158/1078-0432.ccr-03-0470. Clin Cancer Res. 2004. PMID: 15041716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

554 results

Search Page

Filters